Taevas
United Arab EmiratesPharmaceuticals
Product Registration
Market Access for Product-Registration in United Arab Emirates
Navigating the intricate landscape of global product registration requires a robust market access strategy. Taevas Life Sciences empowers your product to achieve timely and sustainable market entry by harmonizing regulatory compliance with payer and stake
Market
Global
Industry
Product-Registration
Regulator
National Health Authorities & Supra-National Agencies
Timeline
8-12 weeks (Initial Strategy)
Deliverables
Market Access Strategy, HTA Roadmap, Payer Engagement Plan
What We Deliver
6 Pillars of Market Access for Global Product Registration
Every engagement covers a structured set of pillars — each customised to your specific category, target segment, and strategic questions.
01
Global Regulatory Intelligence
Comprehensive analysis of regulatory requirements and evolving policies across key target markets. We identify critical pathways and potential hurdles to ensure your product dossier is strategically aligned for global registration.
Horizon Scanning for Emerging Regulations
Comparative Analysis of National Requirements
How It Works
How Our Global Market Access Process Works
A structured engagement — typically delivered in a few weeks.
Step 1 · Week 1-2
Discovery & Landscape Analysis
We begin with an in-depth assessment of your product's profile, target markets, and existing regulatory status. This includes a comprehensive review of global market access requirements and competitive intelligence.
Market Snapshot
Market Overview: Global Product Registration & Market Access
Increasing Regulatory Divergence
Despite harmonization efforts, national market access requirements are increasingly diverging, demanding highly localized strategies even for global products. This complexity necessitates expert guidance to avoid delays.
Evidence Demands Beyond Efficacy
Payers and HTA bodies globally now demand robust evidence of not just clinical efficacy, but also real-world effectiveness, economic value, and patient-reported outcomes, significantly impacting registration success.
Early Engagement is Critical
Proactive engagement with regulatory, HTA, and payer bodies early in the development lifecycle is paramount. This allows for the integration of market access considerations into clinical trial design, streamlining later registration and reimbursement.
What's Included
Deliverables
A structured, decision-ready package of deliverables.
Comprehensive Global Market Access Strategy
A detailed roadmap outlining optimal pathways for product registration, pricing, and reimbursement across target international markets.
Health Technology Assessment (HTA) & Payer Dossier
Fully prepared and optimized submissions tailored to meet the specific evidence requirements of key HTA agencies and payer organizations worldwide.
Global Pricing & Reimbursement Framework
Strategic recommendations for tiered pricing, value-based agreements, and reimbursement models designed for sustainable market entry and revenue generation.
Stakeholder Engagement & Advocacy Plan
A structured approach for identifying, engaging, and building relationships with critical regulatory, clinical, and payer stakeholders globally.
Who This Is For
Use Cases
Biotech Startup
First Global Product Launch
A novel gene therapy company sought to register its first product across multiple continents, lacking internal expertise in diverse market access requirements. Taevas Life Sciences developed a harmonized global strategy.
Outcome
Achieved concurrent regulatory approvals and initiated reimbursement negotiations in key markets, accelerating patient access.
Next Steps
Related Services
FAQ
Frequently Asked Questions
Get Started
Ready to Secure Market Access for Your Product in Global?
Partner with Taevas Life Sciences to navigate the complexities of global product registration and ensure successful, sustainable market entry for your innovations. Our expertise drives your success.
Accelerate Time to Market
Optimize Reimbursement Potential
Mitigate Regulatory Risks
Achieve Sustainable Global Access